Share on StockTwits

Athersys (NASDAQ:ATHX) COO William Lehmann, Jr. sold 12,000 shares of the stock on the open market in a transaction that occurred on Friday, June 20th. The stock was sold at an average price of $1.58, for a total value of $18,960.00. Following the completion of the sale, the chief operating officer now directly owns 500,342 shares in the company, valued at approximately $790,540. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of Athersys (NASDAQ:ATHX) traded down 3.13% on Monday, hitting $1.5499. The stock had a trading volume of 182,217 shares. Athersys has a 52 week low of $1.08 and a 52 week high of $4.33. The stock has a 50-day moving average of $1.58 and a 200-day moving average of $2.77. The company’s market cap is $119.4 million.

Athersys (NASDAQ:ATHX) last released its earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.01. The company had revenue of $0.71 million for the quarter, compared to the consensus estimate of $0.66 million. The company’s revenue for the quarter was up 116.9% on a year-over-year basis. On average, analysts predict that Athersys will post $-0.40 earnings per share for the current fiscal year.

ATHX has been the subject of a number of recent research reports. Analysts at Edison Investment Research reiterated a “neutral” rating on shares of Athersys in a research note on Tuesday, May 6th. Analysts at First Analysis initiated coverage on shares of Athersys in a research note on Tuesday, April 29th. They set an “overweight” rating and a $5.00 price target on the stock.

Athersys, Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.